Contact

Merge Healthcare and Greenway Health Collaborate to Automate the Medical Imaging Ordering Process for Health Care Providers Nationwide Greenway Health, iConnect Network Services, iCNS Merge Healthcare and Greenway Health Collaborate to Automate the Medical Imaging Ordering Process for Health Care Providers Nationwide

Merge Healthcare and Greenway Health Collaborate to Automate the Medical Imaging Ordering Process for Health Care Providers Nationwide

Merge Healthcare, an IBM Company (NYSE: IBM) and leading provider of clinical systems and innovations that seek to transform healthcare, today announced an agreement with Greenway Health which aims to automate medical imaging ordering and results delivery work flows for health care professionals nationwide.
 
Greenway Health’s solutions currently serve 75,000 U.S. health care providers in nearly 10,000 organizations across over 40 specialties, touching more than 100 million lives annually. The collaboration will provide Greenway’s customers with access to Merge’s vendor-neutral referral management platform, called iConnect® Network Services (iCNS). iCNS streamlines the cumbersome and labor-intensive process of placing medical imaging orders, obtaining prior authorizations from payers and delivering results back to referring providers.  These activities are currently performed manually using paper and fax.  
 
“Merge has the infrastructure in place to establish iConnect Network Services as the industry standard for streamlined ordering, prior authorization and results delivery for medical imaging,” said Greg Shilling, vice president of business and corporate development for Greenway Health. “We are pleased to partner with Merge and help our customers achieve even greater efficiencies in their practices with this solution.”
 
Merge’s iCNS creates efficiencies by automating the process of medical image study ordering from within the Greenway EHR, and delivering results to the referring provider.  Providers gain access to the final report and a link to the diagnostic images. This access uses certified EHR technology that meets federally mandated Meaningful Use requirements, which is beneficial to Greenway and the referring provider. iCNS also helps providers ensure that all prescribed medical imaging studies are fulfilled by tracking orders electronically and identifying instances when prescribed studies were not performed.  
 
“Our solution simplifies the process of ordering a medical imaging study in the same way electronic prescribing streamlined the process of order prescription medication years ago,” said Justin Dearborn, chief executive officer of Merge. “Automating the process for the vast majority of imaging orders is truly a game changer.  It enables health care organizations to create an integrated data and imaging management strategy by closing the loop between orders and results, streamlining physician workflows, and promoting the growth and retention of referral business.”

About Merge Healthcare
Merge, an IBM Company, is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge’s enterprise and cloud-based technologies for image intensive specialties provide access using a standard internet browser or mobile device. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs and improve efficiencies, which enhances the quality of healthcare worldwide. For more information, visit merge.com and follow us on Twitter @MergeHealthcare.
 
 
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Contact:
Michael R. Klozotsky
Vice President, Corporate Marketing
312.946.2535
michael.klozotsky@merge.com

 Download this press release >>